Organizational designs for achieving high treatment trial enrollment: A fuzzy-set analysis of the community clinical oncology program

Journal of Oncology Practice

Volumn 8, Issue 5, 2012, Pages 287-291

  Weiner, Bryan J ^a   Jacobs, Sara R ^b   Minasian, Lori M ^b   Good, Marjorie J ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER PREVENTION; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; HUMAN; INFORMATION SCIENCE; MAJOR CLINICAL STUDY; NATIONAL HEALTH ORGANIZATION; ORGANIZATIONAL STRUCTURE; PHYSICIAN; QUALITATIVE ANALYSIS; STUDY DESIGN;

CLINICAL TRIALS AS TOPIC; COMMUNITY HEALTH SERVICES; COMMUNITY-BASED PARTICIPATORY RESEARCH; FUZZY LOGIC; HUMANS; MEDICAL ONCOLOGY; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PATIENT SELECTION; UNITED STATES;

EID: 84872836624     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2011.000507     Document Type: Article

References (24)

1. Minasian LM, Carpenter WR, Weiner BJ, et al: Translating research into evidence-based practice: The National Cancer Institute Community Clinical Oncology Program. Cancer 116:4440-4449, 2010
2. Carpenter WR, Reeder-Hayes K, Bainbridge J, et al: The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care 49:172-179, 2011
3. Laliberte L, Fennell ML, Papandonatos G: The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care 43:471-479, 2005
4. Warnecke RB, Johnson TP, Kaluzny AD, et al: The community clinical oncology program: Its effect on clinical practice. Jt Comm J Qual Improv 21:336-339, 1995
5. Johnson TP, Warnecke RB, Aitken MJ: Changing practice patterns, in Kaluzny AD, Warnecke RB (eds): Managing a Health Care Alliance: Improving Community Cancer Care. San Francisco, CA, Jossey-Bass Publishers, 1996, pp 105-128
6. Nass SJ, Moses HL, Mendelsohn J (eds): A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC, National Academies Press, 2010
7. Carpenter WR, Fortune-Greeley AK, Zullig LL, et al: Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program. Contemp Clin Trials 33:46-54, 2012
8. Carpenter WR, Weiner BJ, Kaluzny AD, et al: The effects of managed care and competition on community-based clinical research. Med Care 44:671-679, 2006
9. McKinney MM, Weiner BJ, Carpenter WR: Building community capacity to participate in cancer prevention research. Cancer Control 13:295-302, 2006
10. McKinney MM, Weiner BJ, Wang V: Recruiting participants to cancer prevention clinical trials: Lessons from successful community oncology networks. Oncol Nurs Forum 33:951-959, 2006
11. Kaluzny AD, Warnecke RB (eds): Managing a Health Care Alliance: Improving Community Cancer Care (ed 1). San Francisco, CA, Jossey-Bass Publishers, 1996
12. Kaluzny AD, Lacey LM, Warnecke R, et al: Predicting the performance of a strategic alliance: An analysis of the Community Clinical Oncology Program. Health Serv Res 28:159-182, 1993
13. Kaluzny AD, Lacey LM, Warnecke R, et al: Using a community cancer treatment trials network for cancer prevention and control research: Challenges and opportunities. Cancer Epidemiol Biomarkers Prev 3:261-269, 1994
14. Kaluzny AD, Lacey LM, Warnecke R, et al: Accrual of patients to randomized clinical trials: Factors affecting cancer prevention and control research. Int J Tech-nol Assess Health Care 10:506-516, 1994
15. Kaluzny AD, Ricketts T 3rd, Warnecke R, et al: Evaluating organizational design to assure technology transfer: The case of the Community Clinical Oncology Program. J Natl Cancer Inst 81:1717-1725, 1989
16. Kaluzny AD, Warnecke RB, Lacey LM, et al: Cancer prevention and control within the National Cancer Institute's clinical trials network: Lessons from the Community Clinical Oncology Program. J Natl Cancer Inst 85:1807-1811, 1993
17. Klabunde C, Kaluzny A, Ford L: Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: Factors affecting accrual. Cancer Epidemiol Biomarkers Prev 4:783-789, 1995
18. Weiner BJ, McKinney MM, Carpenter WR: Adapting clinical trials networks to promote cancer prevention and control research. Cancer 106:180-187, 2006
19. Ragin CC: Redesigning Social Inquiry: Fuzzy Sets and Beyond. Chicago, IL, University of Chicago Press, 2008
20. Ragin CC: Fuzzy-Set Social Science. Chicago, IL, University of Chicago Press, 2000
21. Fiss PC: A set-theoretic approach to organizational configurations. Acad Manage Rev 32:1180-1198, 2007
22. Fiss PC: Building better causal theories: A fuzzy set approach to typologies in organization research. Acad Manage J 54:393-420, 2011
23. Vaisey S: Structure, culture, and community: The search for belonging in 50 urban communes. Am Sociol Rev 72:851-873, 2007
24. Lacey LM, Hynes DM, Kaluzny AD: Performance in quasi-firms: An example from the Community Clinical Oncology Program. J Health Hum Resour Adm 14:307-326, 1992